TY  - BOOK
AU  - Robert J. Fontana et al
TI  - Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study
KW  - Computer science, information & general works
UR  - https://new.zodml.org/sites/default/files/2023-07/efficacy_and_safety_of_8_weeks_of_glecaprevir_pibrentasvir_in_treatment-naive_hcv-infected_patients_with_apri_1_in_a_single-arm_open-label_multicenter_study.pdf
ER  -